"CABG No Better Than PCI In CKD" - Melissa Foster
A study performed by researchers at the Icahn School of Medicine at Mount Sinai shows the presence of chronic kidney disease in patients with diabetes appears to attenuate the benefits of CABG over PCI. In a patient-level pooled analysis, Michael E. Farkouh, MD,associate clinical professor of medicine and cardiology at the Icahn School of Medicine at Mount Sinai, compared outcomes from the randomized COURAGE, BARI 2D and FREEDOM trials. Overall, five-year mortality rates were greater for patients with CKD vs. patients without CKD. Similarly, there were no differences in all-cause mortality between patients who underwent CABG or PCI vs. optimal medical therapy alone. The risk for death was significantly lower among patients who underwent CABG compared with PCI.
— Michael E. Farkouh, MD, Associate Clinical Professor, Medicine, Cardiology, Icahn School of Medicine at Mount Sinai